Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
4.600
-0.150 (-3.16%)
Mar 6, 2026, 10:31 AM EST - Market open
Strata Critical Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Revenue | 197.14 | 146.82 | 225.18 | 146.12 | 67.16 | Upgrade
|
| Revenue Growth (YoY) | 34.28% | -34.80% | 54.11% | 117.58% | 32.92% | Upgrade
|
| Cost of Revenue | 156.02 | 117.23 | 183.06 | 123.85 | 54.31 | Upgrade
|
| Gross Profit | 41.13 | 29.59 | 42.12 | 22.28 | 12.85 | Upgrade
|
| Selling, General & Admin | 51.13 | 49.44 | 82.18 | 67.23 | 42.96 | Upgrade
|
| Research & Development | - | - | 4.63 | 5.55 | 2.16 | Upgrade
|
| Amortization of Goodwill & Intangibles | 2.6 | 1.26 | - | - | - | Upgrade
|
| Operating Expenses | 53.74 | 50.7 | 86.8 | 72.77 | 45.11 | Upgrade
|
| Operating Income | -12.61 | -21.11 | -44.68 | -50.5 | -32.26 | Upgrade
|
| Interest & Investment Income | 4.24 | 7.21 | 8.44 | 3.43 | 0.74 | Upgrade
|
| Other Non Operating Income (Expenses) | 4.28 | -0.85 | 2.13 | 24.23 | -9.15 | Upgrade
|
| EBT Excluding Unusual Items | -4.09 | -14.74 | -34.11 | -22.84 | -40.67 | Upgrade
|
| Merger & Restructuring Charges | -2.05 | -0.04 | - | -3.03 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -5.2 | - | 0.01 | -2.16 | - | Upgrade
|
| Asset Writedown | -2.71 | - | -20.75 | - | - | Upgrade
|
| Legal Settlements | -6.02 | -1.38 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | -2.68 | - | - | Upgrade
|
| Pretax Income | -20.07 | -16.16 | -57.54 | -28.03 | -40.67 | Upgrade
|
| Income Tax Expense | - | - | -1.47 | -0.77 | -3.75 | Upgrade
|
| Earnings From Continuing Operations | -20.07 | -16.16 | -56.08 | -27.26 | -36.92 | Upgrade
|
| Earnings From Discontinued Operations | 61.41 | -11.15 | - | - | - | Upgrade
|
| Net Income | 41.35 | -27.31 | -56.08 | -27.26 | -36.92 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 0.02 | Upgrade
|
| Net Income to Common | 41.35 | -27.31 | -56.08 | -27.26 | -36.94 | Upgrade
|
| Shares Outstanding (Basic) | 82 | 77 | 74 | 71 | 54 | Upgrade
|
| Shares Outstanding (Diluted) | 82 | 77 | 74 | 71 | 54 | Upgrade
|
| Shares Change (YoY) | 5.93% | 5.41% | 3.21% | 31.65% | 26.18% | Upgrade
|
| EPS (Basic) | 0.50 | -0.35 | -0.76 | -0.38 | -0.68 | Upgrade
|
| EPS (Diluted) | 0.50 | -0.35 | -0.76 | -0.38 | -0.68 | Upgrade
|
| Free Cash Flow | -58.51 | -33.38 | -34.46 | -37.86 | -22.12 | Upgrade
|
| Free Cash Flow Per Share | -0.71 | -0.43 | -0.47 | -0.53 | -0.41 | Upgrade
|
| Gross Margin | 20.86% | 20.15% | 18.71% | 15.24% | 19.14% | Upgrade
|
| Operating Margin | -6.40% | -14.38% | -19.84% | -34.56% | -48.04% | Upgrade
|
| Profit Margin | 20.97% | -18.60% | -24.90% | -18.66% | -55.00% | Upgrade
|
| Free Cash Flow Margin | -29.68% | -22.74% | -15.30% | -25.91% | -32.93% | Upgrade
|
| EBITDA | -5.71 | -17.85 | -37.57 | -44.77 | -31.09 | Upgrade
|
| EBITDA Margin | -2.90% | -12.16% | -16.68% | -30.64% | -46.29% | Upgrade
|
| D&A For EBITDA | 6.9 | 3.26 | 7.11 | 5.73 | 1.17 | Upgrade
|
| EBIT | -12.61 | -21.11 | -44.68 | -50.5 | -32.26 | Upgrade
|
| EBIT Margin | -6.40% | -14.38% | -19.84% | -34.56% | -48.04% | Upgrade
|
| Advertising Expenses | - | - | 4.06 | 4.54 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.